Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
44.22
+0.75 (1.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,276 employees as of December 31, 2023. The number of employees decreased by 35 or -2.67% compared to the previous year.
Employees
1,276
Change (1Y)
-35
Growth (1Y)
-2.67%
Revenue / Employee
$409,675
Profits / Employee
-$438,078
Market Cap
4.08B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| ICU Medical | 14,000 |
| Option Care Health | 7,802 |
| Guardant Health | 1,779 |
| Apellis Pharmaceuticals | 706 |
| PROCEPT BioRobotics | 626 |
| ADMA Biologics | 624 |
| Prestige Consumer Healthcare | 570 |
| Avidity Biosciences | 253 |
RARE News
- 1 day ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 day ago - NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH) - GlobeNewsWire
- 2 days ago - Ultragenyx Announces First Patient Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angelman Syndrome - GlobeNewsWire
- 25 days ago - Ultragenyx to Participate in Investor Conferences in December - GlobeNewsWire
- 5 weeks ago - Ultragenyx: Ready For More Growth After Q3 Earnings Beat - Seeking Alpha
- 6 weeks ago - Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST's 17th Annual Global Science Summit - GlobeNewsWire
- 6 weeks ago - Ultragenyx Pharmaceutical Inc. (RARE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire